Targeting VEGFC/VEGFR-3 pathway for lymph node metastasis and reducing the incidence of distant organ metastases have been given a therapeutic approach [9]. The gene discussed is VEGFC; the disease is metastatic malignant neoplasm in the lymph nodes.